Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-12-29

Clinical Trial Update: Single Center Pilot Study of Corticosteroid Discontinuation in Liver Transplant Recipients [Phase 4]

View source ↗

Summary

A single-center Phase 4 pilot study evaluated whether liver transplant recipients could safely discontinue corticosteroids.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PREDNISONE (Prednisone)

Snippet

Sponsor: University of Cincinnati | Conditions: Liver Transplantation | Phase 4 | Status: COMPLETED | Results posted: 2015-12-29